|
[1]
|
Original reports
|
|
Parasites alter the pathological phenotype of lupus nephritis
|
|
Miyake. K.., Adachi. K.., Watanabe. M., Sasatomi. Y., Ogahara. S., Abe. Y., Ito. K., Dan Justin. YK., Saito. T., Nakashima. H. and Hamano. S.
|
|
Autoimmunity, 24:1-10, Jun. 2014.
|
|
|
|
[2]
|
Reactivity of autoantibodies against not only erythrocytes but also hepatocytes in sera of mice with malaria
|
|
Kanda. Y., Kawamura. T., Kobayashi. T., Kawamura. H., Watanabe. H., Abo. T.
|
|
Cellular Immunology, Vol.289(1-2), p162-166, May-Jun 2014.
|
|
|
|
[3]
|
Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice: A New Model of Systemic Lupus Erythematosus
|
|
Yokogawa. M.,Takaishi. M., Nakajima. K., Kamijima. R., Fujimoto. C., Kataoka. S., Terada. Y. and Sano. S.
|
|
Arthritis & Rheumatology, Vol.66(3), p694-706, Mar. 2014.
|
|
|
|
[4]
|
Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice
|
|
Fujita. Y., Fujii. T., Mimori. T., Sato. T., Nakamura. T., Iwao. H., Nakajima A., Miki. M., Sakai. T., Kawanami. T., Tanaka. M., Masaki. Y., Fukushima. T., Okazaki. T. and Umehara. H.
|
|
The Journal of Immunology, Vol.192(3), p979-984, Feb. 2014.
|
|
|
|
[5]
|
Autoimmune disorder phenotypes in Hvcn1-deficient mice
|
|
Sasaki. M., Tojo. A., Okochi. Y., Miyawaki. N., Kamimura. D., Yamaguchi. A., Murakami. M., and Okamura. Y.
|
|
Biochem. J. Vol.450(2), p295-301, Mar. 2013.
|
|
|
|
[6]
|
Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells
|
|
Nishimura Shinsuke and Inoue Hiroshi.
|
|
Autoimmunity, 2013.
|
|
|
|
[7]
|
Suppression of glomerulonephritis in lupus prone NZB/W mice by RN486, a selective inhibitor of Bruton's Tyrosine Kinase
|
|
P.Mina-Osorio, J.LaStant, N.Keirstead, T.Whittard, J.Ayala, S.Stefanova, R. Garrido, N. Dimaano, H. Hilton, M. Giron, K.-Y.Lau, J.Hang, J.Postelnek,Y.Kim, S.Min, A. Patel, J.Woods, M.Ramanujam, J.DeMartino, S.Narula, D.Xu.
|
|
Arthritis & Rheumatism, 2013.
|
|
|
|
[8]
|
Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3
|
|
M.Moritoki, T.Kadowaki, T.Niki, D.Nakano, G.Soma, H.Mori, H.Kobara, T.Masaki, M.Kohno, M.Hirashima.
|
|
PLOS one, 2013.
|
|
|
|
[9]
|
Runx1 Deficiency in CD4+ T Cells Causes Fatal Autoimmune Inflammatory Lung Disease Due to Spontaneous Hyperactivation of Cells
|
|
W.F.Wong, K.Kohu, A.Nakamura, M.Ebina, T.Kikuchi, R.Tazawa, K.Tanaka, S.Kon, T.Funaki, A.Sugahara-Tobinai, C.Y.Looi, S.Endo, R.Funayama,M.Kurokawa, S.Habu, N.Ishii, M.Fukumoto, K.Nakata, T.Takai and M.Satake
|
|
The Journal of Immunology, Vol.188(11), p5408-5420, Jun 2012.
|
|
|
|
[10]
|
Dendritic Cell-Specific Ablation of the Protein Tyrosine Phosphatase Shp1 Promotes Th1 Cell Differentiation and Induces Autoimmunity
|
|
T.Kaneko, Y.Saito, T.Kotani, H.Okazawa, H.Iwamura, M.Sato-Hashimoto, Y.Kanazawa, S.Takahashi, K.Hiromura, S.Kusakari, Y.Kaneko, Y.Murata,H.Ohnishi, Y. Nojima, K.Takagishi and T. Matozaki
|
|
The Journal of Immunology, Vol.188(11), p5397-5407, Jun 2012.
|
|
|
|
[11]
|
Autoimmune disorder phenotypes in Hvcn1-deficient mice
|
|
Sasaki M, Tojo A, Okochi Y, Miyawaki N, Kamimura D, Yamaguchi A, Murakami M and Okamura Y.
|
|
Biochem. J. Vol.450, p295-301, 2013.
|
|
|
|
[12]
|
Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy
|
|
L. A. Norian., T. P. Kresowik., H. M. Rosevear., B. R. James., T. R. Rosean., A. J. Lightfoot., T. A. Kucaba., C. Schwarz., C. J. Weydert., M. D. Henry., T. S. Griffith.
|
|
PLos One 7(2):e31085. 2012
|
|
|
|
[13]
|
Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation
|
|
E.W. Choi., Il S. Shin., S. Y. Park., J. H. Park., J. S. Kim., E. J. Yoon., S. K. Kang., J. C. Ra., S. H. Hong.
|
|
Arthritis & Rheumatism Vol. 64, Issue 1, pages 243-253, 2012
|
|
|
|
[14]
|
Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRLlpr/lpr mice
|
|
S. Sasakia., Y. Nagaia., T. Yanagibashia., Y. Watanabea., M. Ikutania., A. Kariyonea., K. Tsuneyamab., Y. Hiraia., K. Takatsua.
|
|
Molecular Immunology Vol.49,Issue4,611-620, 2012
|
|
|
|
[16]
|
Deamidation of Gliadin Peptides in Lamina Propria: Implications for Celiac Disease
|
|
H. Skovbjerg., D. Anthonsen., E. Knudsen. and H. Sjostrom.
|
|
J of Clinical Immunology Vol.31 ( 6) 1038-1044 , 2011
|
|
|
|
[17]
|
Transgenic Mice that Overexpress Human IL-15 in Enterocytes Recapitulate Both B and T Cell-Mediated Pathologic Manifestations of Celiac Disease
|
|
S. Yokoyama., K. Takada., M. Hirasawa., L. P. Perera., and T. Hiroi.
|
|
J of Clinical Immunology Vol. 31,(6) , 2011
|
|
|
|
[18]
|
Coincidence of autoantibody production with the activation of natural killer T cells in a-galactosylceramide-mediated hepatic injury
|
|
H. Matsumoto., T. Kawamura., T. Kobayashi., Y. Kanda., H. Kawamura., T. Abo.
|
|
Immunology Vol. 133, Issue 1, pages 21-28, 2011
|
|
|
|
[19]
|
Lack of B and T lymphocyte attenuator exacerbates autoimmune disorders and induces Fas-independent liver injury in MRL-lpr/lpr mice
|
|
Y. Oya., N. Watanabe. Y. Kobayashi., T. Owada., M. Oki., K. Ikeda. A. Suto., S. Kagami., K. Hirose., T. Kishimoto., and H. Nakajima.
|
|
Int. Immunol 23 (5): 335-344, 2011
|
|
|
|
[20]
|
Amelioration of systemic lupus erythematosus by withangulatin A in MRL/lpr mice
|
|
L. Sun., L. Zhou., M. Chen., R. Zhong., J. Liu.
|
|
Journal of Cellular Biochemistry Vol. 112, Issue 9, pages 2376-2382, 2011
|
|
|
|
[21]
|
Co-appearance of autoantibody-producing B220low B cells with NKT cells in the course of hepatic injury
|
|
Y. Fujii., H. Kawamura., T. Kawamura., Y. Kanda.,H. Matsumoto., T. Kobayashi., T. Yamamoto., T. Aoyama., T. Abo.
|
|
Cellular Immunology Vol.260,Issue2, 105-112, 2010
|
|
|
|
[22]
|
Identification and characterization of autoantibody-producing B220low B (B-1) cells appearing in malarial infection
|
|
Y. Kanda., H. Kawamura., H. Matsumoto., T. Kobayashi., T. Kawamura., T. Abo.
|
|
Cellular Immunology Vol.263,Issue1, 49-54, 2010
|
|
|
|
[23]
|
Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice
|
|
Z. Gu., K. Akiyama., X. Ma., H. Zhang., X. Feng., G. Yao., Y. Hou., L. Lu., GS. Gilkeson., RM. Silver., X. Zeng., S. Shi., L. Sun
|
|
Lupus Vol.19 No.13, 1502-1514, 2010
|
|
|
|
[24]
|
Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity
|
|
T. Kubo., Y. Uchida., Y. Watanabe., M. Abe., A. Nakamura., M. Ono., S. Akira., and T. Takai.
|
|
J of Experimental Medicine Vol.206 No.9 1971-1982, 2009
|
|
|
|
[25]
|
Deficiency in EBV-induced gene 3 (EBI3) in MRL/ lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis
|
|
T. Igawa., H. Nakashima., A. Sadanaga., K. Masutani., K. Miyake., S. Shimizu., A. Takeda., S. Hamano., and H. Yoshida.
|
|
Modern Rheumatology Vol. 19, Number 1, 33-41, 2009
|
|
|
|
[26]
|
Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis
|
|
E. Esashi1., H. Ito., K. Minehata., S. Saito., Y. Morikawa., A. Miyajima.
|
|
European Journal of Immunology Vol.39,Issue6, 1664-1670, 2009
|
|
|
|
[27]
|
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor a (WSX-1)
|
|
N. Sugiyama., H. Nakashima., T. Yoshimura., A. Sadanaga., S. Shimizu., K. Masutani., T. Igawa., M. Akahoshi., K. Miyake., A. Takeda., A. Yoshimura., S. Hamano., H. Yoshida.
|
|
Ann Rheum Dis 67:1461-1467, 2008
|
|
|
|
[28]
|
Development of autoantibody responses in NC/Nga mice: its prevention by pulverized konjac glucomannan feeding
|
|
N. Onishi., S. Kawamoto., H. Suzuki., M. Hide., and K. Ono.
|
|
Archives of Dermatological Research Vol.300, 95-99, 2008
|
|
|
|
[29]
|
CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
|
|
A. Yoshizaki., Y. Iwata., K. Komura., F. Ogawa., T. Hara., E. Muroi., M. Takenaka., K. Shimizu., M. Hasegawa., M. Fujimoto., T. F. Tedder., and S. Sato.
|
|
Am J Pathol. 172(6): 1650-1663, 2008
|
|
|
|
[30]
|
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice
|
|
A. Sadanaga., H. Nakashima., M. Akahoshi., K. Masutani., K. Miyake., T. Igawa., N. Sugiyama., H. Niiro., M. Harada.
|
|
Arthritis & Rheumatism Vol.56, Issue 5, pages 1618-1628, 2007
|
|
|
|
[31]
|
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.
|
|
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., and Yoshikawa, H.
|
|
Nature 443: 998-1002, 2006
|
|
|
|
[32]
|
Altered cytokine expression in mesenteric lymph nodes in a rat strain (Matsumoto Eosinophilic Shinshu) that spontaneously develops hypereosinophilia
|
|
S. Muto., M. Monnai., Y. Okuhara., M. Murakami., J. Kuroda., T. Ono., K. Matsumoto.
|
|
Immunology Vol. 116, Issue 3, pages 373-380, 2005
|
|
|
|
[33]
|
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice
|
|
Sadanaga, A., Nakashima, H., Masutani, K., Miyake, K., shimizu, S., Igawa, T., Sugiyama, N., Niiro, H., Hirakata, H., and Harada, M.
|
|
Arthritis Rheumatism 52: 3987-3996, 2005
|
|
|
|
[34]
|
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)
|
|
Shimizu, S., Sugiyama, N., Matsutani, K., Sadanaga, A., Miyazaki, Y., Inoue, Y., Akaboshi, M., Katafuchi, R., Hirakata, H., Harada. M., Hamano, S., Nakashima, H., and Yoshida, H.
|
|
J Immunol 175:7185-7192, 2005
|
|
|
|
[35]
|
Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin.
|
|
Sung, Y.Y., Lee, Y.S., Jung, W.H., Kim, H.Y., Cheon, H.G., Yang, S.D., and Rhee, S.D.
|
|
Biochem Biopys Res Commun. 338: 1779-1787, 2005
|
|
|
|
[36]
|
Requirement for CD100-CD72 interactions in fine-tubing of B-cell antigen receptor signaling and homeostatic maintenance ofthe B-cell compartment.
|
|
Kumanogoh, A., Shikina, T., Watanabe, C., Takegahara, N., Suzuki, K., Yamamoto, M., Takamatsu, H., Prasad, D.V.R., Mizui, M., Toyohuku, T., Tamaru, M., Watanabe, D., Parnes, J.R., and Kikutani, H.
|
|
International Immuno, 17: 1277-1282, 2005
|
|
|
|
[37]
|
Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody.
|
|
Takeda, Y., Takeno, M., Iwasaki, M., Kobayashi, H., Kirino, Y., Ueda, A., Nagahama, K., Aoki, I., and Ishigatsubo, Y
|
|
Clin Exp Immunol. 138:237-244, 2004
|
|
|
|
[38]
|
The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis.
|
|
Ishihara, K., Sawa, S., Ikushima, H., Hirota, S., Atsumi, T., Kamimura, D., Park, S.J., Murakami, M., Kitanuma, Y., Iwakura, Y., and Hirano, T.
|
|
International Immunol. 16: 455-465, 2004
|
|
|
|
[39]
|
Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune disease
|
|
Fujimoto, M., Tsutsui, H., Xinshou, O., Tokumoto, M., Watanabe, D., Shima, Y., Yoshimoto, T., Hirakata, H., Kawase, I., Nakanishi, K., Kishimoto, T., and Naka, T.
|
|
International Immunol. 16: 303-314, 2004
|
|
|
|
[40]
|
Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity.
|
|
Hanada, T., Yoshida, H., Kato, S., Tanaka, K., Matsutani, K., Tsukada, J., Nomura, Y., Mimata, H., Kubo, M., and Yoshimura, A.
Immunity: 19: 437-450, 2003
|
|
|
|
[41]
|
Association of Cathepsin E Deficiency with Development of Atopic Dermatitis
|
|
Tsukuba et al.
|
|
J Biochem (Tokyo). 134: 893-902, 2003
|
|
|
|
[42]
|
Fc RIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
|
|
Yajima, K., Nakamura, A., Sugahara, A., and Takai, T.
|
|
Eur J Immunol, 33:(4) 1020-1029, 2003
|
|
|
|
[43]
|
A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis
|
|
T. Atsumi., K. Ishihara., D. Kamimura., H. Ikushima., T. Ohtani., S. Hirota., H. Kobayashi., S. Park., Y. Saeki., Y. Kitamura. and T. Hirano
|
|
J Exp Med, 196, Number 7, 979-990, 2002
|
|
|
|
[44]
|
A novel assay kits for autoantibodies rate on spontaneous autoimmune model mice.
|
|
Kikukawa, T, Kojima, M., and Abe, C.
|
|
Jap J Inflammation 20: 697-701, 2000
|
